A 52-year-old man presents with cognitive decline, chorea, and psychiatric symptoms. Family history reveals his father died at age 55 with similar symptoms, and his paternal grandfather also had progressive dementia and movement disorder. Genetic testing shows 45 CAG repeats in the huntingtin gene. His 25-year-old daughter, currently asymptomatic, requests genetic counseling. Evaluate the most ethically and clinically appropriate approach to her request.
Q2
A 65-year-old woman with early Alzheimer's disease (MMSE 23/30) on donepezil presents with worsening behavioral symptoms. She has developed paranoid delusions that her husband is stealing from her and has become physically aggressive. Her husband requests antipsychotic medication. She has no other medical conditions. Labs including TSH, B12, and metabolic panel are normal. Evaluate the most appropriate management strategy considering risk-benefit analysis.
Q3
A 78-year-old man with moderate Alzheimer's disease (MMSE 16/30) on donepezil develops progressive gait instability and urinary incontinence over 3 months. His daughter reports his memory seems worse. CT head shows enlarged ventricles with periventricular lucency. You suspect normal pressure hydrocephalus superimposed on Alzheimer's disease. Evaluate the most appropriate next step to guide management decisions.
Q4
A 58-year-old woman presents with rapidly progressive dementia over 8 weeks, myoclonus, and ataxia. MRI shows cortical ribboning and hyperintensity in the caudate and putamen on DWI sequences. EEG shows periodic sharp wave complexes. CSF analysis shows normal cell count and glucose, elevated protein, and positive 14-3-3 protein. Analysis of her clinical presentation suggests which molecular mechanism is primarily responsible?
Q5
A 70-year-old man with diabetes and hypertension presents with stepwise decline in cognitive function over 3 years, with periods of stability followed by sudden worsening. He has emotional lability and urinary incontinence. MMSE is 21/30 with prominent executive dysfunction. MRI shows multiple lacunar infarcts in basal ganglia and periventricular white matter hyperintensities. Which pathophysiological mechanism best explains his white matter changes?
Q6
A 62-year-old man presents with progressive personality changes over 2 years. His wife reports he has become socially inappropriate, making crude comments and shoplifting. He has lost interest in his hobbies and shows poor judgment. Memory testing is relatively preserved. MRI shows asymmetric frontotemporal atrophy, more prominent on the right. Which neurotransmitter system change would most likely be found on autopsy in this patient?
Q7
A 76-year-old woman with known Alzheimer's disease (MMSE 18/30) presents to the emergency department with acute agitation and visual hallucinations over the past 24 hours. She is currently taking donepezil. Vital signs show temperature 38.9°C (102°F), blood pressure 145/88 mmHg, and heart rate 102/min. Urinalysis shows 50+ WBCs and positive nitrites. What is the most appropriate management approach?
Q8
A 55-year-old man with a history of chronic alcohol use presents with confusion and ataxia. His wife reports he has been making up stories to fill in memory gaps. Physical examination reveals horizontal nystagmus and ophthalmoplegia. He is given intravenous thiamine, and symptoms partially improve. Two weeks later, he continues to have significant anterograde amnesia and confabulation. What is the most appropriate next step in management?
Q9
A 68-year-old woman presents with a 6-month history of visual hallucinations of small children in her home, fluctuating cognition, and frequent falls. Her husband reports she acts out her dreams at night. Physical examination reveals cogwheel rigidity and bradykinesia. MMSE score is 24/30. What is the most likely diagnosis?
Q10
A 72-year-old man is brought to the clinic by his daughter who reports that over the past year, he has had progressive memory decline and difficulty managing his finances. He frequently forgets appointments and repeats questions. Mini-Mental State Examination (MMSE) score is 22/30, with deficits in recall and orientation. MRI shows bilateral hippocampal atrophy. What is the most appropriate initial pharmacological treatment?
Cognitive disorders (dementia) US Medical PG Practice Questions and MCQs
Question 1: A 52-year-old man presents with cognitive decline, chorea, and psychiatric symptoms. Family history reveals his father died at age 55 with similar symptoms, and his paternal grandfather also had progressive dementia and movement disorder. Genetic testing shows 45 CAG repeats in the huntingtin gene. His 25-year-old daughter, currently asymptomatic, requests genetic counseling. Evaluate the most ethically and clinically appropriate approach to her request.
A. Test her but withhold results until preventive treatments become available
B. Refer for formal genetic counseling with psychiatric evaluation before testing (Correct Answer)
C. Defer testing until she develops symptoms since no treatment exists
D. Recommend testing only if she plans to have children
E. Order immediate genetic testing given high pretest probability
Explanation: ***Refer for formal genetic counseling with psychiatric evaluation before testing***
- For an incurable adult-onset neurodegenerative disorder like **Huntington's disease**, predictive testing must be preceded by thorough **psychiatric screening** and genetic counseling to assess the psychological impact of the results.
- This protocol ensures the patient has the **autonomy** and emotional support to handle the significant **suicide risk** and life-altering implications associated with a positive diagnosis.
*Test her but withhold results until preventive treatments become available*
- Withholding medical results violates the ethical principle of **autonomy** and the patient's right to their own health information.
- Genetic testing for **Huntington's** is designed for life planning (e.g., finances, reproduction), and information should not be delayed by the physician if the patient requests it after counseling.
*Defer testing until she develops symptoms since no treatment exists*
- While there is no cure, the patient has the right to **predictive testing** as an adult to make informed decisions regarding **career planning** and marriage.
- Forcing a patient to wait until **phenotypic expression** (chorea or cognitive decline) occurs ignores the patient's goals for psychological certainty.
*Recommend testing only if she plans to have children*
- Although **reproductive counseling** (e.g., IVF with PGD) is a common reason for testing, it is not the only valid reason to seek a diagnosis.
- Restricting testing to procreation ignores other vital factors like **disability insurance** planning and long-term financial management.
*Order immediate genetic testing given high pretest probability*
- Ordering the test immediately without **pre-test counseling** is considered clinically inappropriate due to the high risk of depression and psychiatric decompensation.
- The **presymptomatic protocol** specifically mandates multiple sessions to ensure the patient won't regret knowing their status, especially given the **autosomal dominant** inheritance pattern.
Question 2: A 65-year-old woman with early Alzheimer's disease (MMSE 23/30) on donepezil presents with worsening behavioral symptoms. She has developed paranoid delusions that her husband is stealing from her and has become physically aggressive. Her husband requests antipsychotic medication. She has no other medical conditions. Labs including TSH, B12, and metabolic panel are normal. Evaluate the most appropriate management strategy considering risk-benefit analysis.
A. Start quetiapine as it has the safest side effect profile in dementia
B. Increase donepezil dose and add memantine for behavioral symptoms
C. Initiate behavioral interventions and SSRI trial before considering antipsychotics (Correct Answer)
D. Hospitalize for acute psychiatric stabilization with haloperidol
E. Start low-dose risperidone for symptom control
Explanation: ***Initiate behavioral interventions and SSRI trial before considering antipsychotics***
- Non-pharmacological **behavioral interventions** and environmental modifications are the first-line treatment for the **behavioral and psychological symptoms of dementia (BPSD)**.
- **SSRIs** like citalopram or sertraline are preferred over antipsychotics for managing agitation and aggression due to a superior **safety profile** and lower risk of serious adverse events.
*Start quetiapine as it has the safest side effect profile in dementia*
- All atypical antipsychotics, including **quetiapine**, carry an **FDA black box warning** for increased risk of **mortality** and cardiovascular events (stroke) in elderly patients with dementia.
- Quetiapine often lacks strong evidence for efficacy in managing **dementia-related psychosis** compared to other agents and can cause significant **orthostatic hypotension**.
*Increase donepezil dose and add memantine for behavioral symptoms*
- While **memantine** may have modest benefits for cognitive symptoms in moderate-to-severe disease, its efficacy for acute **paranoid delusions** and **physical aggression** is limited.
- Increasing the **cholinesterase inhibitor** dose focuses on cognitive decline rather than directly addressing the primary distress of the caregiver and the patient's immediate behavioral risks.
*Hospitalize for acute psychiatric stabilization with haloperidol*
- **Haloperidol** and other first-generation antipsychotics carry a higher risk of **extrapyramidal symptoms** and mortality in the elderly compared to newer agents.
- Hospitalization should be a last resort, as changes in environment often exacerbate **delirium** and agitation in patients with **Alzheimer's disease**.
*Start low-dose risperidone for symptom control*
- **Risperidone** is sometimes used for severe symptoms, but it should only be initiated after non-pharmacological methods and **SSRIs** have failed.
- The risk of **cerebrovascular adverse events** and metabolic disturbances outweighs the benefits in a patient with early-stage dementia where less harmful interventions have not been tried.
Question 3: A 78-year-old man with moderate Alzheimer's disease (MMSE 16/30) on donepezil develops progressive gait instability and urinary incontinence over 3 months. His daughter reports his memory seems worse. CT head shows enlarged ventricles with periventricular lucency. You suspect normal pressure hydrocephalus superimposed on Alzheimer's disease. Evaluate the most appropriate next step to guide management decisions.
A. Obtain MRI with flow studies to confirm hydrocephalus, then shunt
B. Perform large-volume lumbar puncture and assess gait improvement (Correct Answer)
C. Add memantine to current regimen and reassess in 3 months
D. Discontinue donepezil as it may worsen urinary incontinence
E. Proceed directly to ventriculoperitoneal shunt placement
Explanation: ***Perform large-volume lumbar puncture and assess gait improvement***
- A **large-volume lumbar puncture (tap test)** is the gold standard for predicting **shunt responsiveness** in patients suspected of having **Normal Pressure Hydrocephalus (NPH)**.
- Because this patient has underlying **Alzheimer’s disease**, it is crucial to determine if his gait and cognitive symptoms are reversible before committing to an invasive surgical procedure.
*Obtain MRI with flow studies to confirm hydrocephalus, then shunt*
- **Cine-MRI flow studies** can show CSF stroke volume but are not reliable enough to confirm the diagnosis or predict clinical outcomes on their own.
- Decisions for **permanent shunting** should not be based solely on imaging when there is evidence of co-morbid neurodegenerative disease.
*Add memantine to current regimen and reassess in 3 months*
- Adding **memantine** may help manage **Alzheimer’s symptoms**, but it does not address the potentially reversible mechanical issue of **NPH**.
- Delaying assessment for 3 months allows for potentially permanent **neurological decline** if hydrocephalus is the primary cause of his worsening state.
*Discontinue donepezil as it may worsen urinary incontinence*
- While **cholinesterase inhibitors** can cause urinary urgency, the patient's presentation of enlarged ventricles and **gait instability** strongly suggests a structural etiology rather than drug side effects.
- Discontinuing dementia medication could lead to a significant **cognitive crash** without addressing the underlying cause of the new physical symptoms.
*Proceed directly to ventriculoperitoneal shunt placement*
- Proceeding directly to surgery is inappropriate in patients with **mixed dementia** because the presence of **Alzheimer’s** significantly reduces the success rate of the shunt.
- A **positive tap test** is necessary to justify the risks of **ventriculoperitoneal shunt placement**, such as subdural hematomas or infection.
Question 4: A 58-year-old woman presents with rapidly progressive dementia over 8 weeks, myoclonus, and ataxia. MRI shows cortical ribboning and hyperintensity in the caudate and putamen on DWI sequences. EEG shows periodic sharp wave complexes. CSF analysis shows normal cell count and glucose, elevated protein, and positive 14-3-3 protein. Analysis of her clinical presentation suggests which molecular mechanism is primarily responsible?
A. Beta-amyloid oligomers disrupting synaptic function
B. Autoimmune antibodies against neuronal surface antigens
C. Viral-induced cytotoxic T-cell mediated neuronal destruction
D. Excitotoxicity from glutamate receptor dysfunction
E. Misfolded prion protein inducing conformational change in normal prion protein (Correct Answer)
Explanation: ***Misfolded prion protein inducing conformational change in normal prion protein***
- The patient presents with classic **Creutzfeldt-Jakob disease (CJD)**, where **PrPSc** (scrapie form) triggers the conversion of normal **PrPC** (cellular form) from an alpha-helix to a **beta-pleated sheet**.
- This cascading process leads to **spongiform encephalopathy**, characterized by the rapid progression of **myoclonus**, **ataxia**, and **14-3-3 protein** in the CSF.
*Beta-amyloid oligomers disrupting synaptic function*
- This mechanism is characteristic of **Alzheimer's disease**, which presents with a much slower, chronic progression of cognitive decline over years rather than weeks.
- Alzheimer's lacks the **periodic sharp wave complexes** on EEG and the specific **striatal hyperintensity** seen on MRI DWI sequences.
*Autoimmune antibodies against neuronal surface antigens*
- While **Autoimmune Encephalitis** (e.g., anti-NMDA receptor) can cause rapid neuropsychiatric symptoms, it usually features **lymphocytic pleocytosis** in the CSF.
- It does not produce the pathognomonic **cortical ribboning** or consistent **14-3-3 protein** positivity found in CJD.
*Viral-induced cytotoxic T-cell mediated neuronal destruction*
- This refers to viral encephalitis or **Progressive Multifocal Leukoencephalopathy (PML)**, which typically shows **white matter lesions** rather than grey matter involvement.
- Viral causes would typically show **elevated white cell counts** or specific viral DNA in the CSF, which are absent here.
*Excitotoxicity from glutamate receptor dysfunction*
- **Glutamate excitotoxicity** is a secondary mechanism in various neurodegenerative processes and acute insults like **stroke**, but it is not the primary driver of CJD.
- It does not explain the unique **transmissible nature** or the specific **periodic complexes** identified on this patient's EEG.
Question 5: A 70-year-old man with diabetes and hypertension presents with stepwise decline in cognitive function over 3 years, with periods of stability followed by sudden worsening. He has emotional lability and urinary incontinence. MMSE is 21/30 with prominent executive dysfunction. MRI shows multiple lacunar infarcts in basal ganglia and periventricular white matter hyperintensities. Which pathophysiological mechanism best explains his white matter changes?
A. Venous congestion from dural sinus thrombosis
B. Amyloid angiopathy causing microhemorrhages
C. Atherosclerotic occlusion of large vessels
D. Direct neurotoxic effect of hyperglycemia
E. Chronic hypoperfusion causing oligodendrocyte death and demyelination (Correct Answer)
Explanation: ***Chronic hypoperfusion causing oligodendrocyte death and demyelination***
- Periventricular **white matter hyperintensities** result from **small vessel disease**, where chronic ischemia leads to the loss of **oligodendrocytes** and subsequent **demyelination**.
- This patient's **stepwise decline**, cognitive impairment, and **lacunar infarcts** are classic signatures of **vascular dementia** caused by ongoing subcortical hypoperfusion.
*Venous congestion from dural sinus thrombosis*
- Typically presents with **acute headache**, seizures, and **papilledema** rather than a multi-year stepwise cognitive decline.
- MRI would show **venous infarcts** and thrombus in the sinuses, not chronic periventricular **white matter hyperintensities**.
*Amyloid angiopathy causing microhemorrhages*
- Characterized by **lobar hemorrhages** in older adults, often associated with Alzheimer's disease pathology.
- While it causes cognitive decline, its hallmark is **cortical microbleeds** rather than the extensive periventricular ischemia and **lacunar infarcts** seen here.
*Atherosclerotic occlusion of large vessels*
- Large vessel disease typically leads to **territorial infarcts** (e.g., MCA distribution) with focal neurological deficits rather than diffuse white matter changes.
- While a risk factor, it does not directly explain the specific **periventricular hyperintensities** and **lacunae** resulting from small penetrating artery disease.
*Direct neurotoxic effect of hyperglycemia*
- Chronic hyperglycemia causes damage via **oxidative stress** and **advanced glycation end-products**, but it is not the primary driver of white matter demyelination.
- Its impact on the brain is predominantly mediated through **microvascular damage** and accelerated **atherosclerosis** rather than a direct neurotoxic effect on oligodendrocytes.
Question 6: A 62-year-old man presents with progressive personality changes over 2 years. His wife reports he has become socially inappropriate, making crude comments and shoplifting. He has lost interest in his hobbies and shows poor judgment. Memory testing is relatively preserved. MRI shows asymmetric frontotemporal atrophy, more prominent on the right. Which neurotransmitter system change would most likely be found on autopsy in this patient?
A. Amyloid plaques and neurofibrillary tangles in hippocampus
B. Loss of dopaminergic neurons in substantia nigra
C. Tau or TDP-43 protein accumulation in frontal cortex (Correct Answer)
D. Alpha-synuclein deposits in cortical Lewy bodies
E. Decreased acetylcholine in nucleus basalis of Meynert
Explanation: ***Tau or TDP-43 protein accumulation in frontal cortex***
- The patient's presentation of **behavioral variant frontotemporal dementia (bvFTD)** is characterized by **socially inappropriate behavior**, poor judgment, and **asymmetric frontotemporal atrophy** on imaging.
- The pathological hallmark of FTD is the accumulation of either **hyperphosphorylated tau** or **TDP-43 (TAR DNA-binding protein 43)** inclusions in the affected cortex.
*Amyloid plaques and neurofibrillary tangles in hippocampus*
- These are the pathological features of **Alzheimer's disease**, which typically presents with **early memory deficit** rather than personality changes.
- In Alzheimer's, atrophy is usually more pronounced in the **hippocampus** and **parietal lobes** rather than the frontal lobe.
*Loss of dopaminergic neurons in substantia nigra*
- This pathological change is specific to **Parkinson's disease**, which primarily presents with **motor symptoms** like resting tremor and bradykinesia.
- While behavioral changes can occur, they follow primary motor dysfunction and are not associated with focal **frontotemporal atrophy**.
*Alpha-synuclein deposits in cortical Lewy bodies*
- This finding is characteristic of **Dementia with Lewy Bodies (DLB)**, which features **visual hallucinations** and **fluctuating levels of consciousness**.
- DLB usually presents with **REM sleep behavior disorder** and parkinsonism rather than isolated behavioral disinhibition.
*Decreased acetylcholine in nucleus basalis of Meynert*
- A significant reduction in **acetylcholine** is the neurochemical basis for the cognitive decline seen in **Alzheimer's disease**.
- Patients with FTD usually have relatively preserved **cholinergic systems** but show deficits in **serotonergic** and **dopaminergic** pathways.
Question 7: A 76-year-old woman with known Alzheimer's disease (MMSE 18/30) presents to the emergency department with acute agitation and visual hallucinations over the past 24 hours. She is currently taking donepezil. Vital signs show temperature 38.9°C (102°F), blood pressure 145/88 mmHg, and heart rate 102/min. Urinalysis shows 50+ WBCs and positive nitrites. What is the most appropriate management approach?
A. Add memantine to current regimen for worsening dementia
B. Treat urinary tract infection with antibiotics and provide supportive care (Correct Answer)
C. Discontinue donepezil as it may be causing delirium
D. Obtain head CT to rule out stroke as cause of acute change
E. Start haloperidol for agitation and hallucinations
Explanation: ***Treat urinary tract infection with antibiotics and provide supportive care***
- The patient exhibits an acute onset of **agitation, visual hallucinations, and fever**, which defines **delirium** superimposed on her pre-existing Alzheimer's dementia.
- Urinalysis findings of **pyuria and nitrites** indicates a **urinary tract infection (UTI)** as the primary trigger; treating the underlying medical cause is the first-line management for delirium.
*Add memantine to current regimen for worsening dementia*
- The acute onset of symptoms over 24 hours is characteristic of **delirium**, not the typical slow, progressive decline of **dementia**.
- **Memantine** is used for moderate-to-severe Alzheimer's but will not address the acute physiological trigger of the current presenting symptoms.
*Discontinue donepezil as it may be causing delirium*
- **Donepezil** (a cholinesterase inhibitor) is generally not a common cause of delirium and is helpful in managing cognitive symptoms in Alzheimer's.
- With a clear source of infection (UTI) and fever present, the **infection** is a much more likely cause of the acute mental status change than the stable home medication.
*Obtain head CT to rule out stroke as cause of acute change*
- While a stroke can cause acute changes, the presence of **fever**, tachycardia, and **positive nitrites** points strongly toward an infectious etiology rather than a cerebrovascular event.
- **Neuroimaging** is generally reserved for patients with focal neurological deficits or those where the source of delirium remains unknown after an initial workup.
*Start haloperidol for agitation and hallucinations*
- Antipsychotics like **haloperidol** carry a **Black Box Warning** for increased mortality in elderly patients with dementia and should be avoided as a first-line therapy.
- Pharmacological management of agitation should only be considered if the patient is a **danger to themselves or others** and after non-pharmacological interventions and treatment of the underlying cause have failed.
Question 8: A 55-year-old man with a history of chronic alcohol use presents with confusion and ataxia. His wife reports he has been making up stories to fill in memory gaps. Physical examination reveals horizontal nystagmus and ophthalmoplegia. He is given intravenous thiamine, and symptoms partially improve. Two weeks later, he continues to have significant anterograde amnesia and confabulation. What is the most appropriate next step in management?
A. Initiate benzodiazepine taper for alcohol withdrawal
B. Start donepezil for memory improvement
C. Obtain brain MRI to rule out structural lesion
D. Perform lumbar puncture to exclude infectious etiology
E. Continue high-dose thiamine supplementation and cognitive rehabilitation (Correct Answer)
Explanation: ***Continue high-dose thiamine supplementation and cognitive rehabilitation***
- The patient presents with **Wernicke encephalopathy** (confusion, ataxia, ophthalmoplegia) progressing to **Korsakoff syndrome**, characterized by **anterograde amnesia** and **confabulation**.
- While the acute ocular signs respond quickly to thiamine, the chronic amnestic stage requires continued **high-dose thiamine** and **long-term supportive care** to prevent further neurotoxicity and attempt recovery.
*Initiate benzodiazepine taper for alcohol withdrawal*
- **Benzodiazepines** are used to treat acute alcohol withdrawal (tremors, seizures, delirium tremens) but do not address the **thiamine deficiency** underlying memory loss.
- There is no clinical evidence of **autonomic hyperactivity** (tachycardia, hypertension) to suggest active withdrawal in this two-week follow-up.
*Start donepezil for memory improvement*
- **Donepezil** is a cholinesterase inhibitor used for **Alzheimer's disease** and has no proven efficacy in treating the memory deficits of **Korsakoff syndrome**.
- The memory loss here is due to damage in the **mammillary bodies** and **dorsomedial nucleus of the thalamus**, not primarily a cholinergic deficit.
*Obtain brain MRI to rule out structural lesion*
- While an MRI might show **atrophy of the mammillary bodies**, the diagnosis is clinical based on history of **chronic alcohol use** and the classic **triad** or pentad of symptoms.
- A structural lesion is unlikely given the classic response to **thiamine** in the acute phase and the characteristic presentation of **confabulation** over two weeks.
*Perform lumbar puncture to exclude infectious etiology*
- **Lumbar puncture** is used if meningitis or encephalitis is suspected, but the patient lacks symptoms like **fever**, **nuchal rigidity**, or photophobia.
- The persistent amnesia and alcohol history strongly point toward a **nutritional deficiency** rather than a central nervous system infection.
Question 9: A 68-year-old woman presents with a 6-month history of visual hallucinations of small children in her home, fluctuating cognition, and frequent falls. Her husband reports she acts out her dreams at night. Physical examination reveals cogwheel rigidity and bradykinesia. MMSE score is 24/30. What is the most likely diagnosis?
A. Frontotemporal dementia
B. Lewy body dementia (Correct Answer)
C. Vascular dementia
D. Parkinson's disease with dementia
E. Alzheimer's disease with behavioral disturbance
Explanation: ***Lewy body dementia***
- Characterized by the classic triad of **fluctuating cognition**, detailed **visual hallucinations**, and spontaneous **parkinsonism** (rigidity and bradykinesia) [1].
- The presence of **REM sleep behavior disorder** (acting out dreams) is a highly specific core clinical feature that supports this diagnosis over other forms of dementia.
*Frontotemporal dementia*
- Primarily presents with early **personality changes**, disinhibition, or **language deficits** rather than early hallucinations or parkinsonism [1].
- Typically occurs in younger patients and does not show the **fluctuating levels of alertness** seen in this case.
*Vascular dementia*
- Usually follows a **step-wise decline** in cognitive function related to documented cerebrovascular events or strokes [2].
- Focuses on **executive dysfunction** and focal neurological signs rather than REM sleep disorders or well-formed visual hallucinations.
*Parkinson's disease with dementia*
- Diagnosed only when **motor symptoms** are present for at least **one year** before the onset of cognitive decline (the "one-year rule").
- In this patient, cognitive and visual symptoms are prominent early features concurrent with or preceding established parkinsonism.
*Alzheimer's disease with behavioral disturbance*
- Initial symptoms are typically **anterograde amnesia** and short-term memory loss, which are more persistent than fluctuating [3].
- While hallucinations can occur late in the disease, they are not a defining early feature like the **parkinsonian signs** observed here.
Question 10: A 72-year-old man is brought to the clinic by his daughter who reports that over the past year, he has had progressive memory decline and difficulty managing his finances. He frequently forgets appointments and repeats questions. Mini-Mental State Examination (MMSE) score is 22/30, with deficits in recall and orientation. MRI shows bilateral hippocampal atrophy. What is the most appropriate initial pharmacological treatment?
A. Vitamin E supplementation
B. Memantine
C. Galantamine and memantine combination
D. Ginkgo biloba extract
E. Donepezil (Correct Answer)
Explanation: ***Donepezil***
- **Cholinesterase inhibitors** like donepezil are first-line monotherapy for **mild-to-moderate** Alzheimer’s disease (MMSE 10–26).
- This patient's **progressive memory decline**, MMSE score of 22, and **hippocampal atrophy** are hallmark features of Alzheimer's requiring immediate symptomatic treatment.
*Vitamin E supplementation*
- While it has been studied for its antioxidant properties, high-dose **Vitamin E** provides no proven benefit in reversing cognitive decline.
- It is not recommended as a primary pharmacological treatment and carries risks of increased **all-cause mortality** at high doses.
*Memantine*
- This **NMDA receptor antagonist** is typically indicated for **moderate-to-severe** Alzheimer's disease (MMSE < 18).
- Although safe, it is not the preferred initial monotherapy for patients whose symptoms are currently in the **mild stage**.
*Galantamine and memantine combination*
- Combination therapy is usually reserved for patients who show **clinical worsening** on a cholinesterase inhibitor alone or have advanced disease.
- Starting two agents simultaneously is not standard practice for a patient newly diagnosed with **mild cognitive impairment**.
*Ginkgo biloba extract*
- **Ginkgo biloba** is an herbal supplement that lacks consistent clinical evidence to support its efficacy in treating or preventing dementia.
- It is not a recognized **FDA-approved** or guideline-recommended treatment for Alzheimer’s disease.
